Benny Abraham Kaipparettu
Affiliations: | Baylor College of Medicine, Houston, TX |
Google:
"Benny Kaipparettu"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Abdulkareem NM, Bhat R, Powell RT, et al. (2022) Screening of GPCR drugs for repurposing in breast cancer. Frontiers in Pharmacology. 13: 1049640 |
Attri KS, Park JH, Kaipparettu BA. (2022) Redox regulation of hybrid metabolic state in breast cancer metastasis. Annals of Translational Medicine. 10: 1032 |
Rajamanickam S, Park JH, Subbarayalu P, et al. (2022) Targeting aberrant replication and DNA repair events for treating breast cancers. Communications Biology. 5: 493 |
Tripathi S, Park JH, Pudakalakatti S, et al. (2022) A mechanistic modeling framework reveals the key principles underlying tumor metabolism. Plos Computational Biology. 18: e1009841 |
Jia D, Park JH, Kaur H, et al. (2021) Towards decoding the coupled decision-making of metabolism and epithelial-to-mesenchymal transition in cancer. British Journal of Cancer |
Mukhopadhyay UK, Oturkar CC, Adams C, et al. (2019) TP53 Status as a Determinant of Pro- versus Anti-tumorigenic Effects of Estrogen Receptor-beta in Breast Cancer. Journal of the National Cancer Institute |
Jia D, Lu M, Jung KH, et al. (2019) Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways. Proceedings of the National Academy of Sciences of the United States of America |
Jia D, Park JH, Jung KH, et al. (2018) Elucidating the Metabolic Plasticity of Cancer: Mitochondrial Reprogramming and Hybrid Metabolic States. Cells. 7 |
Zhao N, Cao J, Xu L, et al. (2018) Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer. The Journal of Clinical Investigation |
Vangapandu H, Havranek O, Ayres M, et al. (2017) B cell receptor signaling regulates metabolism in Chronic Lymphocytic Leukemia. Molecular Cancer Research : McR |